• 回答数

    4

  • 浏览数

    109

李利李利5
首页 > 论文发表 > 曾发表7篇SCI顶级论文

4个回答 默认排序
  • 默认排序
  • 按时间排序

咩~咩~羊

已采纳

近五年课题:

1. microRNA124调控微量金属元素吸收抑制胰腺癌细胞的机制研究, 黑龙江省重点基金,2017.10-2020.10,20万,ZD2017001

2. miRNAs对动物组织干细胞的调控及其机制研究, 中央高校基本科研业务费专项资金,2016.4-2020.3,50万,2572016EAJ3

参加人:梁洋、赵翊丞、王春生、何梅、于泽、李旭艳、金家民、孔德麟

3. miR-124/EGFR信号调控胰腺祖细胞增殖机制研究,国家自然科学基金面上项目,2015.1-2018.12,86万,31472159.

参加人:赵翊丞、梁洋、张振武、何梅、李旭艳、梁杰、李云超、孔德麟

近五年SCI:

1. Ze Yu, Hao Wang, Yilin Fang, Liangliang Lu, Minghao Li, Bingru Yan, Yuzhe Nie and Chunbo Teng. Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6. Journal Of Cellular Biochemistry. 2020, 121(3): 2318-2329.

2. Miao Liu, Wen Yu, Jing Jin, Mingjun Ma, Tiezhu An, Yuzhe Nie and Chun-Bo Teng. Copper promotes sheep pancreatic duct organoid growth by activation of an antioxidant protein 1-dependent MEK-ERK pathway. American Journal Of Physiology-Cell Physiology. 2020, 318(4): C806-C816.

3. Zhang Z, Zhai W, Liang J, Chen Z, Ma M, Zhao Y, Liang Y, Li X, Teng C-B: Mutual inhibitions between epidermal growth factor receptor signaling and miR-124a control pancreatic progenitor proliferation. Journal Of Cellular Physiology 2019, 234:12978-12988.

4. Yang L, Zhu Y, Kong D, Gong J, Yu W, Liang Y, Nie Y, Teng C-B: EGF suppresses the expression of miR-124a in pancreatic beta cell lines via ETS2 activation through the MEK and PI3K signaling pathways. International Journal Of Biological Sciences 2019, 15:2561-2575.

5. Yu Z, Wang H, Fang Y, Lu L, Li M, Yan B, Nie Y, Teng C: Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6. Journal Of Cellular Biochemistry 2019.

6. (非通讯)Zhang F, Ma D, Liu T, Liu YH, Guo J, Song J, Wu Q, Pan Y, Zhang Y, Guo C, Teng, C, Jin, L: Expansion and Maintenance of CD133-Expressing Pancreatic Ductal Epithelial Cells by Inhibition of Transforming Growth Factor-beta Signaling. Stem Cells And Development 2019, 28:1236-1252.

7. Yu Z, Zhou R, Zhao Y, Pan Y, Liang H, Zhang J-S, Tai S, Jin L, Teng C-B: Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Proliferation 2019, 52.

8. Yu Z, Yu Z, Chen Z, Yang L, Ma M, Lu S, Wang C, Teng C, Nie Y: Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy. Journal Of Cellular Physiology 2019, 234:20648-20661.

9. Yin W, Yang L, Kong D, Nie Y, Liang Y, Teng C-B: Guanine-rich RNA binding protein GRSF1 inhibits myoblast differentiation through repressing mitochondrial ROS production. Experimental Cell Research 2019, 381:139-149.

10. Qi H, Teng M, Liu M, Liu S, Li J, Yu H, Teng C, Huang Z, Liu H, Shao Q, et al: Biomass-derived nitrogen-doped carbon quantum dots: highly selective fluorescent probe for detecting Fe3+ ions and tetracyclines. Journal Of Colloid And Interface Science 2019, 539:332-341.

11. Ma R, Wang Y, Qi H, Shi C, Wei G, Xiao L, Huang Z, Liu S, Yu H, Teng C, Li, H, Murugadoss, V, Zhang, J, Wang, Y, Guo, Z: Nanocomposite sponges of sodium alginate/graphene oxide/polyvinyl alcohol as potential wound dressing: In vitro and in vivo evaluation. Composites Part B-Engineering 2019, 167:396-405.

12. Liu J, Cao L, Zhao N, Feng Y, Yu Z, Li Y, Teng C, Hu J, Li T: miR-338-3p inhibits A549 lung cancer cell proliferation and invasion by targeting AKT and beta-catenin signaling pathways. Molecular Medicine Reports 2019, 20:33-40.

13. Li X, Teng C, Ma J, Fu N, Wang L, Wen J, Wang T-Y: miR-19 family: A promising biomarker and therapeutic target in heart, vessels and neurons. Life Sciences 2019, 232.

14. Kong D, He M, Yang L, Zhou R, Yan Y-Q, Liang Y, Teng C-B: MiR-17 and miR-19 cooperatively promote skeletal muscle cell differentiation. Cellular and molecular life sciences : CMLS 2019.

15. He M, Zhou D, Ding N-Z, Teng C-B, Yan X-C, Liang Y: Common Carp mef2 Genes: Evolution and Expression. Genes 2019, 10.

16. Jin J, Teng C, Li T: Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials. Drug Design Development And Therapy 2018, 12:475-480.

17. Zhou RT, He M, Yu Z, Liang Y, Nie YZ, Tai S, Teng CB: Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of NEDD9 expression and its downstream Akt and ERK signaling pathways. Oncotarget 2017, 8:56351-56363.

18. Zhao Y, Song Y, Yao L, Song G, Teng C: Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases. DNA And Cell Biology 2017, 36:77-94.

19. Li X, Zhang Z, Li Y, Zhao Y, Zhai W, Yang L, Kong D, Wu C, Chen Z, Teng C-B: miR-18a counteracts AKT and ERK activation to inhibit the proliferation of pancreatic progenitor cells. Scientific Reports 2017, 7.

20. Zhao Y, Wang T, Yu Z, Wang H, Liu B, Wu C, Teng C-B: Inhibiting cyprinid herpesvirus-3 replication with CRISPR/Cas9. Biotechnology Letters 2016, 38:573-578.

21. Zhao Y, Wang T, Yao L, Liu B, Teng C, Ouyang H: Classical swine fever virus replicated poorly in cells from MxA transgenic pigs. Bmc Veterinary Research 2016, 12.

22. Li XY, Zhai WJ, Teng CB: Notch Signaling in Pancreatic Development. International Journal Of Molecular Sciences 2016, 17:19

23. Yang J, Zhou F, Xing R, Lin Y, Han Y, Teng C, Wang Q: Development of Large-Scale Size-Controlled Adult Pancreatic Progenitor Cell Clusters by an Inkjet-Printing Technique. Acs Applied Materials & Interfaces 2015, 7:11624-11630.

24. Kong D, Zhao Y, Men T, Teng C-B: Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy. Journal Of Drug Targeting 2015, 23:125-133.

25. He M, Teng C-B: Divergence and codon usage bias of Betanodavirus, a neurotropic pathogen in fish. Molecular Phylogenetics And Evolution 2015, 83:137-142.

26. Zhao Y, Dai Z, Liang Y, Yin M, Ma K, He M, Ouyang H, Teng C-B: Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Scientific Reports 2014, 4

201 评论

厦门混世小魔王

国内发表过sci影响因子200+以上的人有张凯。张凯在读博期间,以第一作者发表7篇论文,影响因子都超过了10,以第二作者和共同作者的身份在16篇杂志上发表SCI总影响因子高达230,还获得了2016-2017年度北京科技大学三好学生、2017-2018年度材料学院十佳学术之星等荣誉称号。

352 评论

妞妞们要健康

土木工程发表7篇SCI论文属于高水平,属于研究领域的顶尖水平,因为SCI论文的审查标准比较严格,只有同行评审认可的优秀论文才能发表。

259 评论

言小旭他妈

土木工程发表7篇SCI论文的水平取决于论文的内容、质量和影响力。论文的内容必须具有学术价值,质量要高,影响力要大。发表7篇SCI论文的水平可以说是非常不错的,可以说是在学术界有一定影响力的。

317 评论

相关问答

  • sci论文发表了7篇能进高校吗

    你好,一般来说高中生能够发SCI论文的是非常稀少的,这种情况非常罕见。这要看它的影响因子,也要看是哪一方面的文章,如果影响因子非常高,学术价值非常高,那么是有可

    小七木瓜 4人参与回答 2023-12-05
  • 发表7篇论文

    已经有了很好的发展,而且现在这个女孩已经长大了,看起来特别的秀气,颜值也非常的高。

    依我以希 5人参与回答 2023-12-11
  • 发表论文7篇

    已经有了很好的发展,而且现在这个女孩已经长大了,看起来特别的秀气,颜值也非常的高。

    厚德悟远 6人参与回答 2023-12-07
  • 仪征市发表sci期刊论文7篇

    博士以上SCI论文可以代表本专业在全球的最先进技术以及发展趋势。而且论文级别一般是按照SCI期刊的影响因子进行划分的,影响因子越高,就说明SCI期刊论文的等级越

    柠檬心的颜色 3人参与回答 2023-12-11
  • 发表7篇sci论文什么水平

    1、若作者是博士毕业生,读书期间就获得了九篇文章,论文质量如何,也是个高手。2、若作者是教授,水平就一般了。CSCI是指《中国科学引文索引9》,被誉为中国的SC

    冒冒爱雨雨 2人参与回答 2023-12-12